Insomnia could increase people’s risk of type 2 diabetes, study finds7 April 2022People who have difficulty getting to sleep or staying asleep had higher blood sugar levels than people who rarely had sleep issues, new research has found. The University of Bristol-led findings suggest insomnia could increase people’s risk of type 2 diabetes, and that lifestyle or pharmacological treatments that improve insomnia could help to prevent or treat the condition.
Aspirin may improve 3-month survival for patients critically ill with COVID-1922 March 2022Antiplatelet drugs such as aspirin have little effect on the need for life support in COVID-19, but they may improve survival in the following months according to a new international study led in the UK by researchers at the University of Bristol and Imperial College London.
Superior Covid protection from better face masks, research shows3 March 2022New research from the universities of Surrey and Bristol and ESPCI Paris has shown that FFP2 (filtering facepiece) respirator masks are five times more efficient at filtering particles which carry the Covid-19 virus than cloth masks.
New study of 46-million adults in England confirms blood clot risk with COVID-19 vaccine is very small22 February 2022The risk of blood clots after COVID-19 vaccinations is very low finds a new study of 46-million adults in England. The research, which involved University of Bristol academics, showed that people vaccinated with Oxford-AstraZeneca or Pfizer-BioNTech had a lower risk of all venous clots (such as deep vein thrombosis and pulmonary embolism) and all arterial clots (such as strokes and heart attacks), particularly in people over 70 years.
Bristol's FluoretiQ announces the closure of £1.1 million funding round21 February 2022University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections.
SARS-CoV-2 Spike protein binds to heart’s vascular cells potentially contributing to severe microvascular damage3 February 2022A new study has shown how SARS-CoV-2 may contribute to severe microvascular damage seen in severely-ill COVID-19 patients by transforming human heart vascular cells into inflammatory cells, without infecting them. The University of Bristol-led research, published in Clinical Science, indicates blocking antibodies could represent a new treatment to alleviate cardiovascular complications.
Sweet pressure – scientists discover link between high blood pressure and diabetes1 February 2022The long-standing enigma of why so many patients suffering with high blood pressure (known as hypertension) also have diabetes (high blood sugar) has finally been cracked by an international team led by the universities of Bristol, UK, and Auckland, New Zealand.
New environment-friendly shield could offer better protection during dental surgery17 January 2022Dental patients and practitioners could be better protected from COVID-19 and other airborne viruses and bacteria thanks to the development of a new environment-friendly shield by a multidisciplinary team from the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW). The shield could also increase the number of patients seen by dentists and help reduce procedure wait times.